Bioactivity:

PSMA617-TCMC is a derivative of PSMA-617 with structure modification, in which the caroboxy groups in DOTA ring is replaced by TCMC macrocycle. PSMA-617 is a ligand used to make 177Lu-PSMA-617, which is a radioactive molecule to fight cancer.

CAS nr:

T28467

Purity:

98%

Molecular Weight:

1659,52

SMILES:

O=C(O)CC[C@@H](C(O)=O)NC(N[C@H](C(O)=O)CCCCNC([C@@H](NC([C@H]1CC[C@H](CNC(NC2=CC=C(CC3N(CC(N)=O)CCN(CC(N)=O)CCN(CC(N)=O)CCN(CC(N)=O)C3)C=C2)=S)CC1)=O)CC4=CC=C5C=CC=CC5=C4)=O)=O.O=C(O)C(F)(F)F.O=C(O)C(F)(F)F.O=C(O)C(F)(F)F.O=C(O)C(F)(F)F

Formula:

C65H86F12N14O21S

Pathway:

Target: